Search

Your search keyword '"Falk, Hendrik"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Falk, Hendrik" Remove constraint Author: "Falk, Hendrik"
45 results on '"Falk, Hendrik"'

Search Results

1. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

3. Correction: Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

4. Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

5. HBO1 is required for the maintenance of leukaemia stem cells

7. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth

8. Method for simultaneous tracking of thousands of unlabeled cells within a transparent 3D matrix

10. Abstract 1130: First-in-class KAT6A/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER+ breast cancer with KAT6A dysregulation

11. Competition Policy in Banking in the European Union

12. Common Ownership in the Dutch Banking Market

13. State Aid and Competition in the European Banking Markets

14. Currency Compositions of International Reserves and the Euro Crisis

15. Currency Compositions of International Reserves and the Euro Crisis

18. Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and Differentiation

19. Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents

20. Videolaryngoscopy to aid transoesophageal echocardiography probe insertion

21. Bank Mergers in the Financial Crisis – A Competition Policy Perspective

22. Bank mergers in the financial crisis - a competition policy perspective

23. HBO1 is required for the maintenance of leukaemia stem cells

24. Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A

26. Laienreanimation – Kann wirklich jeder ein Leben retten?

27. Small-Molecule Inhibition of PRMT5 Induces Translational Stress and p53 in JAK2V617F Mutant Myeloproliferative Neoplasms

29. Abstract 5371: PRMT5 inhibitors as novel treatment for cancers

30. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

33. Bedeutung der Spleißvarianten des stimulatorischen Gα-Proteins für die Rezeptor-abhängige Adenylylcyclase-Aktivierung

35. Abstract 4029: BL-011256 is a novel VEGFR3 selective inhibitor, which suppresses tumor lymphatics and lymph node metastasis in an animal model of melanoma

37. Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling

39. Selective Inhibitors of Arginine Methyl Transferase 5 (PRMT5) As a Novel Treatment for β-Thalassemia and Sickle Cell Disease.

44. Selective Inhibitors of Arginine Methyl Transferase 5 (PRMT5) As a Novel Treatment for beta-Thalassemia and Sickle Cell Disease

45. Development of small molecule STING agonists that can evoke host anti-cancer immune defences following local or systemic delivery

Catalog

Books, media, physical & digital resources